# Atosiban

## Tractocile inj 5mL  7.5mg/mL infusion

| 藥物代碼           | ITRA5                                                                                                                                                                                                                                                                                                                                                                                                             |
|:-------------------|:------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Delay imminent preterm birth in pregnant women with regular uterine contractions of at least 30 seconds duration at a rate of >=4 per 30 mins; cervical dilation of 1-3 cm (0-3 for nulliparas) & effacement of >=50%, age >=18 years; gestational age of 24-33 weeks, normal fetal heart rate.                                                                                                                   |
| 副作用             | Very common (>10%): nausea. Common (1-10%): headache, dizziness, hot flushes, vomiting, tachycardia, hypotension, inj site reactions, hyperglycemia. Uncommon (0.1%-1%): fever, insomnia, pruritus, rash. Rare (<0.1%): incidental cases of uterine haemorrhage/uterine atony and one case of allergic reaction were reported.                                                                                    |
| 禁忌               | Gestation ages <24 weeks or >33 weeks premature rupture of the membranes > 30 weeks of gestation, intrauterine growth retardation & abnormal fetal heart rate, antepartum uterine hemorrhage requiring immediate delivery, eclampsia & severe pre-eclampsia requiring delivery, intrauterine fetal death, suspected intrauterine infection, placenta praevia, abruptio placenta, abnormal or high-risk pregnancy. |
| 藥物保存方式       | 2-8℃                                                                                                                                                                                                                                                                                                                                                                                                              |
| 用法用量           | Initially 6.75 mg via slow IV over 1 min, followed by continuous IV infusion at 18 mg/hr for 3 hr. Thereafter, administer 6 mg/hr via continuous IV infusion up to 45 hr.                                                                                                                                                                                                                                         |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                      |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                          |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                               |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                               |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                  |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                               |
| 注射劑給藥建議途徑 | IVD, IVP, IVPUSH                                                                                                                                                                                                                                                                                                                                                                                                  |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                               |
| 輸注點滴液         | 【D5W】 可選 仿單建議  【N/S】 可選 仿單建議  【L/R】 可選 仿單建議                                                                                                                                                                                                                                                                                                                                               |
| IVP 用法建議       | 初始劑量：6.75mg/0.9mL 推注1分鐘                                                                                                                                                                                                                                                                                                                                                                                  |
| IVD 用法建議       | 維持劑量:100~300 mcg/min                                                                                                                                                                                                                                                                                                                                                                                          |
| 注意事項           | 1.不可與其他藥物混合 2.維持劑量:100~300 mcg/min 3.起始劑量:7.5mg/mL,推注時間至少1分鐘                                                                                                                                                                                                                                                                                                                             |

